|
PRITCHARD REGIMENS [12]
|
|
Alauddin 2011 [20]
|
India
|
P
|
N/A
|
Prospective cohort
|
N
|
|
Bhattarcharjee 2011 [21]
|
India
|
P
|
N/A
|
RCT
|
Y
|
|
Pm
|
4 g loading; 6 g/8 h maintenance
|
|
Bhattacharya 2010 [22]
|
India
|
P
|
N/A
|
Case Control
|
N
|
|
Bhalla 1994 [23]
|
India
|
Pm
|
12 g loading
|
RCT
|
Y
|
|
Chowdhury 2009 [24]
|
India
|
P
|
N/A
|
RCT
|
Y
|
| | |
Zm
|
0.6 g/h maintenance
| | |
|
Chissell 1994 [25]
|
South Africa
|
P
|
N/A
|
RCT
|
Y
|
|
Zm
|
6 g loading 2 g/h maintenance
|
|
Crowther 1990 [26]
|
Zimbabwe
|
P
|
N/A
|
RCT
|
Y
|
|
Ekele 2005 [27]
|
Nigeria
|
P
|
N/A
|
Prospective cohort
|
N
|
|
Malapaka 2011 [28]
|
India
|
P
|
N/A
|
RCT
|
Y
|
| | |
Pm
|
4 g loading; 2 g/3 h maintenance
| | |
|
Mahajan 2009 [29]
|
India
|
Pm (A)
|
10 g loading
|
Prospective cohort
|
N
|
|
Pm (B)
|
6 g loading
|
|
Manorot 1996 [30]
|
Thailand
|
P
|
N/A
|
RCT
|
Y
|
|
Z
|
N/A
|
|
Mundle 2011 [31]
|
India
|
P
|
N/A
|
RCT
|
Y
|
| | |
Z
|
N/A
| | |
|
Shoaib 2009 [32]
|
Pakistan
|
P
|
N/A
|
Prospective cohort
|
N
|
| | |
Pm
|
No maintenance dose
| | |
|
ZUSPAN REGIMENS [33]
|
|
Aali 2007 [34]
|
Iran
|
Zm
|
2 g/h maintenance
|
Prospective cohort
|
N
|
|
Belfort 2003 [35]
|
14 countries
|
Z or Zm
|
6 g loading; 2 g/h maintenance
|
RCT
|
Y
|
|
Coetzee 1998 [36]
|
South Africa
|
Z
|
N/A
|
RCT
|
Y*
|
|
Dayicioglu 2003 [37]
|
Turkey
|
Zm
|
4.5 g loading; 1.8 g/h maintenance
|
Prospective cohort
|
N
|
|
Deshmukh 1985 [38]
|
Bangladesh
|
Z or Zm
|
1 g/h maintenance for 8 h
|
Prospective cohort
|
Y
|
|
Dommisse 1988 [39]
|
South Africa
|
Z or Zm
|
2 g/h maintenance
|
RCT
|
Y
|
|
Phuapradit 1993 [40]
|
Thailand
|
Zm
|
5 g loading
|
Prospective cohort
|
N
|
|
PRITCHARD OR ZUSPAN
|
|
Altman 2002 [9]
|
33 countries
|
P or Z
|
N/A
|
RCT
|
Y*
|
|
Eclampsia Trial Collaborative Group 1995 [8]
|
9 countries
|
P or Z1
|
N/A
|
RCT
|
Y
|
|
P or Z2
|
N/A
|
RCT
|
Y
|
|
DHAKA REGIMENS [41]
|
|
Begum 2001 [41]
|
Bangladesh
|
D
|
N/A
|
Prospective cohort
|
N
|
|
Shilva 2007 [42]
|
India
|
D
|
N/A
|
RCT
|
Y*
|
| | |
Dm
|
12 g loading
|
